Accessia Health: Hereditary Angioedema - Public Insurance

Funded
About
The Accessia Health: Hereditary Angioedema - Public Insurance program provides substantial benefits for patients requiring medications such as Berinert, Cinryze, Firazyr, Kalbitor, Ruconest, Haegarda, Takhzyro, Icatibant Acetate, Orladeyo, and Sajazir. It offers various forms of assistance including copay, premium, and ancillary services to qualified individuals living in the US or a US Territory. Accessia Health ensures access to these vital treatments while assisting with copayment and other related costs, benefiting those with hereditary angioedema and specific needs based on clinical evaluations.
Insurance requirements: Medicare / Medicaid
Enrollment Forms
Accessia Health: Hereditary Angioedema - Public Insurance
Benefits
$7500 annual maximum benefit
Program Requirements
Valid only for residents in the US and Puerto Rico
Enrollment Required: Yes
Coverage Required: No
Needs Based: Yes
Activation Required: No
Program Details
Fund may include assistance types such as copayment, premium, ancillary services, infusion and nursing services, or travel
Coverage of items or services under Medical Expenses is determined at the sole discretion of Accessia Health; and is subject to change based on clinical correlation with covered diagnosis. Questions related to specific items covered under Medical Expenses require clinical review for compliance purposes, and responses will be provided within 35 business days. Inquiries about coverage of medical expenses should be directed to assistance@accessiahealth.org
Patients can apply by calling the helpline or online at https://patient.accessiahealth.org/
Patients must provide diagnosis, demographic & contact information, supporting income documentation and health insurance details when applying
A completed Medical Care Provider Statement is required to process Premium Assistance Programs
Patients must utilize their grant award at a minimum of every 4 months or their award will close. Once patient's award closes, they will need to reapply
For copayment assistance with FDA approved and indicated medications for the program diagnosis, an Accessia Health pharmacy benefit card is mailed to the patient upon approval
For all other assistance, a payment card will be provided for patient to pay eligible vendors and/or providers directly
Claims must be submitted within 4 months from the date of service to be considered for payment
To remain eligible for assistance, patients must notify Accessia Health of any change in insurance, contact, or financial details
Other Tools for Firazyr